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To the editor: 
I read with great interest the article recently published in the Journal of PeriAnesthesia Nursing that 
examined the utility of using dexmedetomidine (DEX) as an adjunct to midazolam and fentanyl for 
procedural sedation and analgesia during radiofrequency catheter ablation (RFCA) of atrial 
fibrillation (AF).1 With the view towards advancing knowledge about more effective medications for 
sedation in this challenging context, I offer the following insights for readers to consider regarding 
this study.  
While it is recommended in guidelines for reporting observational research that matching should be 
taken into account in analysis, the statistical tests used to compare data between cases and matched 
controls did not account for the dependent nature of the data.1, 2 Analysis that does not account for 
the dependent nature of matched data could result in an inaccurate strength of association between 
the dependent and independent variables or a change in the significance of the findings.3 For this 
reason, the use of the Wilcoxon rank sum test instead of the Wilcoxon signed ranks test could have 
lead to errors in analysis of the important outcomes measured in this study.1, 4 It cannot be inferred 
from the content of the paper whether the appropriate statistical test for categorical variables 
(McNemar’s test) was used. Readers should note these potential limitations when considering the 
authors conclusion that the utility of DEX is limited in the context of RFCA of AF due to a lack of 
significant reduction in consumption of midazolam and fentanyl.1 The non-significant findings from 
this small non-randomised study should not discourage further more rigorous research in this field. 
Instead, the results presented should be used to launch more rigorous examinations. An adequately 
powered randomised controlled trial is required to more precisely determine if adding DEX to 
midazolam and fentanyl is a more effective sedation regimen than standard practice during RFCA of 
AF. 
Following are some important issues to consider in such an evaluation. Firstly, a simple reduction in 
dose of midazolam and fentanyl is not an indicator that a sedation strategy incorporating DEX is 
more effective than standard practice. As the authors noted in their introduction, patient response 
to sedative medications is variable.1, 5 Thus, more appropriate outcomes to measure in a study that 
aimed to compare the efficacy between the novel sedation strategy incorporating DEX and usual 
practice include patient satisfaction, interruptions to the procedure due to ineffective sedation and 
length of recovery.6, 7 
Second, in order for research to be translated to clinical practice, further evaluations of the use of 
DEX during electrophysiology should not compare monitored anesthesia care with cardiologist-
directed nurse-administered sedation, unless of course the extra costs associated with monitored 
anesthesia care are considered when determining efficacy. Costs were not considered in the present 
study.1 Conducting a study that compares usual practice with a cardiologist-directed nurse-
administered sedation strategy incorporating DEX would provide more useful insights for clinical 
practice, however, because regardless of cost considerations, simply gaining access to monitored 
anesthesia care for sedation in the cardiac catheterisation laboratory is difficult in many institutions 
around the world.8, 9 
Of note, though, for such research to be feasible it would need to be a truly collaborative venture 
between the cardiologists and nurses involved in direct patient care as well as anesthesiologists.  An 
interdisciplinary approach, incorporating specialist knowledge from anesthesiologists for the 
development of protocols for medication titration and patient monitoring as well as comprehensive 
education programs, would ensure the cardiologists and nurses involved in the provision of patient 
care posses the necessary knowledge and skills to promptly detect clinical deterioration and 
effectively apply interventions to support or restore cardiac and respiratory function during DEX 
administration. The data reported in this study about the haemodynamic effects of DEX in patients 
undergoing RFCA of AF will considerably aid the development of such protocols and education 
programs to be used in future research.1 In this regard, I encourage the authors as well as other 
researchers to build on the results of this study and more rigorously examine the safety and 
effectiveness of DEX in the context of sedation during RFCA of AF. Indeed, my own recent research, 
in which the perceptions of nurses who are involved in administering sedation in Australian and New 
Zealand cardiac catheterisation laboratories were explored, also indicated that such research is 
urgently required.6 
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